AIToday
AI Stocks & MarketsAI Business & IndustryYahoo Finance AIPublished: Jul 15, 2026, 01:00 JST2 min read

Nvidia gains fresh analyst support; TD Cowen, Goldman Sachs rate as buy

Nvidia gains fresh analyst support; TD Cowen, Goldman Sachs rate as buy

Key takeaway

  • Two major Wall Street analysts have reiterated "Buy" ratings on Nvidia, with TD Cowen targeting $275 and Goldman Sachs targeting $285 per share.

  • Analysts highlight Nvidia's integrated hardware-software platform and durable AI spending across industries as reasons to own the stock, though they note it has lagged the recent microchip rally and may offer near-term opportunity.

3 Key Points

  1. What happened

    TD Cowen analyst Joshua Buchalter reiterated a "Buy" rating on Nvidia with a $275 price objective on July 8, citing the company's integrated hardware-and-software platform as an underappreciated competitive edge. Goldman Sachs analyst James Schneider also issued a "Buy" rating with a $285 price objective, viewing Nvidia as left out of the current rally in microchip stocks.

  2. Why it matters

    Buchalter argues that AI spending will remain durable across different applications and customers, with industry-specific AI deployments expected to be a major growth driver over time. Schneider's view that Nvidia has been excluded from recent microchip gains suggests the stock may have room to run if the rally broadens.

  3. What to watch

    Both analysts see upside from here—Buchalter's $275 target and Schneider's $285 target—though Nvidia's position relative to other AI-exposed stocks remains competitive.

Ask the AI about this article →

Context & Analysis

Nvidia faces a nuanced investment narrative, with both analyst upgrades and caution from the same report. The two fresh "Buy" ratings—at $275 from TD Cowen and $285 from Goldman Sachs—converge on the company's structural advantages: its proprietary CUDA ecosystem and seamless integration of hardware and software. However, the framing differs slightly. TD Cowen emphasizes durability of AI spending across diverse use cases and a shift toward industry-specific deployments as a future growth engine. Goldman Sachs, meanwhile, notes that Nvidia has been absent from the recent semiconductor rally, which could represent a catch-up opportunity if the sector broadens.

The report itself, however, includes a counterweight: the authors acknowledge potential in Nvidia but suggest other AI stocks may offer better risk-reward and highlight an undervalued competitor positioned to benefit from Trump-era tariffs and onshoring. This tension—between analyst enthusiasm and editorial skepticism about relative value—reflects ongoing debate about whether Nvidia's premium valuation fully prices in its competitive moat.

FAQ

What is Nvidia's core competitive advantage according to these analysts?
Both analysts point to Nvidia's integrated hardware and software platform that works seamlessly together, as well as its CUDA ecosystem, which enables industries from autonomous vehicles to scientific research.
Why do analysts think Nvidia stock may rise?
TD Cowen believes AI spending is durable across applications and customers, with industry-specific AI deployments expected to be a major growth driver. Goldman Sachs sees Nvidia as left out of the current microchip rally, offering an investment opportunity.
Yahoo Finance AIRead Original Article

Get the latest AI Stocks & Markets news every morning

For example, today's edition would include:

  • NVIDIA Leads 5 AI Stocks to Watch in SeptemberYahoo Finance AI · 33m ago
  • Palantir stock near fair value; AI data debate weighsYahoo Finance AI · 6h ago
  • CrowdStrike Stock Climbs as AI Security Demand SurgesYahoo Finance AI · 9h ago

AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.

Free · takes 30 seconds · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. Q&As are published on this page for other readers too.

Related Articles

Next articleZoetis acquires VitalRADS to build AI-powered animal diagnostics